FUTURE WOCKHARDT Peer Comparison

Study the consolidated report of peers competition of future-wockhardt to do a comparitive study of latest price, market cap, net income and net profit.

# Company Name Last Price Market Cap.
(Rs. Cr.)
Net Income Net Profit
1 WOCKHARDT 634.95 4291.3 979.13 -13.9
2 MOREPEN LAB 16.60 892.91 218.72 10.49
3 BLISS GVS 176.85 1790.63 244.05 18.79
4 SYNGENE 493.95 12064 533.9 100.1
5 MERCK 1064.30 7546 231.03 40.71
6 ALEMBIC PHARMA 500.30 11094.16 926.95 131.48
7 RPG LIFE 396.80 399.91 68.8 1.54
8 KOPRAN 70.90 168.69 99.71 7.68
9 PIRAMAL ENTERPRISES 2761.50 45448.31 3679.67 338.11
10 GLAXO PHARMA 2451.80 21679.74 751.22 123.03
11 VIMTA LABS 129.00 427.68 53.58 6.77

CIN: U67190WB2003PTC096617. Trading in Commodities is done through our Group Company Dynamic Commodities Pvt. Ltd. The company is also engaged in Proprietory Trading apart from Client Business.
“2019 © COPYRIGHT DYNAMIC EQUITIES PVT. LTD.”

Disclaimer: There is no guarantee of profits or no exceptions from losses. The investment advice provided are solely the personal views of the research team. You are advised to rely on your own judgment while making investment / Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. You should read and understand the Risk Disclosure Documents before trading/Investing.

Disclosure: We, Dynamic Equities Private Limited are also engaged in Proprietory Trading apart from Client Business. In case of any complaints/grievances, clients may write to us at compliance@dynamiclevels.com

  • Download our Mobile App
  • Available on Google Play
  • Available on App Store
  • RSS